Insider Transactions last 24 months for Collegium Pharmaceutical, Inc.  -  NSDQ: COLL

 
Transactions
All Buy Sell Option Exercise
Filer's Name
Relationship/
Title
Trans.
Date
Trans. Type
Ownership Type
Security Type
Shares
Price
Trans.
Value
Total Shares Owned
Smith Thomas BEVP and Chief Medical Officer08/29/2025DSDirectCOM17,478$38.42$671,576.4270,264
Dreyer ScottEVP & Chief Commercial Officer08/18/2025DSDirectCOM16,389$38.21$626,171.25103,613
Dreyer ScottEVP & Chief Commercial Officer08/18/2025AMDirectCOM16,389$21.34$349,741.26120,002
Santini GinoDirector08/15/2025DSDirectCOM5,405$37.19$201,018.4495,042
Santini GinoDirector08/15/2025AMDirectCOM15,000$13.45$201,750.00100,447
Rubric Capital Management LpOther08/13/2025DSIndirectCOM25,000$37.85$946,250.003,132,743
Dreyer ScottEVP & Chief Commercial Officer08/13/2025DSDirectCOM4,861$38.03$184,880.84103,613
Dreyer ScottEVP & Chief Commercial Officer08/13/2025AMDirectCOM4,861$21.34$103,733.74108,474
Freund John GordonDirector08/08/2025DSIndirectCOM11,659$34.36$400,640.5523,129
Freund John GordonDirector06/09/2025DSDirectCOM6,601$30.62$202,149.0270,658
Freund John GordonDirector06/09/2025AMDirectCOM15,000$13.45$201,750.0077,259
Paya Carlos VDirector05/15/2025AADirectCOM19,582$0.00$0.0019,582
Santini GinoDirector05/15/2025AADirectCOM9,791$0.00$0.0085,447
Freund John GordonDirector05/15/2025AADirectCOM9,791$0.00$0.0062,259
Balice-Gordon Rita J.Director05/15/2025AADirectCOM9,791$0.00$0.0056,279
Bohlin Garen GDirector05/15/2025AADirectCOM9,791$0.00$0.0062,259
Lurker NancyDirector05/15/2025AADirectCOM9,791$0.00$0.0022,517
Fallon John A.Director05/15/2025AADirectCOM9,791$0.00$0.0064,634
Dreyer ScottEVP & Chief Commercial Officer03/21/2025DSDirectCOM18,881$30.03$566,983.21103,613
Tupper ColleenEVP & Chief Financial Officer03/21/2025DSDirectCOM6,396$30.03$192,068.68156,667
Dreyer ScottEVP & Chief Commercial Officer03/20/2025DSDirectCOM1,927$30.00$57,810.96122,494
Tupper ColleenEVP & Chief Financial Officer03/20/2025DSDirectCOM1,206$30.00$36,181.33163,063
Dieter DavidEVP & General Counsel03/17/2025AADirectCOM68,449$0.00$0.0068,449
Dreyer ScottEVP & Chief Commercial Officer03/14/2025DSDirectCOM2,255$30.00$67,661.05124,421
Tupper ColleenEVP & Chief Financial Officer03/14/2025DSDirectCOM977$30.00$29,313.32164,269
1   2  3  4  5  Next Last  You are at page 1 of 5 pages
Transaction Type Key
First letter: A = Acquired, D = Disposed
Second letter:
A = Grant, award or other acquisition pursuant to Rule 16b-3(d) C = Conversion of derivative security | D = Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e) | E = Expiration of short derivative position | F = Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3. | G = Gift | H = Expiration (or cancellation) of long derivative position with value received | I = Discretionary transaction in accordance with Rule 16b-3(f) | J = Other | L = Small acquisition under Rule 16a-6 | M = Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | O = Exercise of out-of-the-money derivative security | P = Open market or private purchase | S = Open market or private sale | U = Disposition pursuant to a tender of shares in a change of control transaction | W = Acquisition or disposition by will or the laws of descent and distribution | X = Exercise of in-the-money or at-the-money derivative security | Z = Deposit into or withdrawal from voting trust
Export Table Data to Excel Send to Excel